FFCP PHASE2:Hg19::chr3:169490834..169490863,+: Difference between revisions
From FANTOM5_SSTAR
Jump to: navigation, search
(Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=entrezgene:55892 |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding |HGNC=HGNC:14955 |TSScla...") |
No edit summary |
||
Line 2: | Line 2: | ||
|DHSsupport=supported | |DHSsupport=supported | ||
|DPIdataset=robust | |DPIdataset=robust | ||
|EntrezGene= | |EntrezGene=55892 | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | ||
|HGNC= | |HGNC=14955 | ||
|TSSclassifier=strong | |TSSclassifier=strong | ||
|UniProt= | |UniProt=Q9NPC7,B2R6C9 | ||
|association_with_transcript=0bp_to_ENST00000349841,ENST00000356716,ENST00000392733,NM_001185118,NM_018657,NR_033702,NR_033703,uc003fft.2,uc003ffu.2,uc003ffv.2,uc011bpm.1_5end | |association_with_transcript=0bp_to_ENST00000349841,ENST00000356716,ENST00000392733,NM_001185118,NM_018657,NR_033702,NR_033703,uc003fft.2,uc003ffu.2,uc003ffv.2,uc011bpm.1_5end | ||
|cluster_id=chr3:169490834..169490863,+ | |cluster_id=chr3:169490834..169490863,+ |
Latest revision as of 14:59, 16 September 2015
Short description: | p4@MYNN |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_4_at_MYNN_5end |
Coexpression cluster: | C8_Natural_CD8_Basophils_CD4_CD14_Peripheral_CD34 |
Association with transcript: | 0bp_to_ENST00000349841, ENST00000356716, ENST00000392733, NM_001185118, NM_018657, NR_033702, NR_033703, uc003fft.2, uc003ffu.2, uc003ffv.2, uc011bpm.1_5end |
EntrezGene: | MYNN |
HGNC: | 14955 |
UniProt: | Q9NPC7B2R6C9 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p4@MYNN |
---|
0
2
4
6
8
10
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphoid lineage restricted progenitor cell | 1.28e-29 | 52 |
lymphocyte | 5.51e-29 | 53 |
common lymphoid progenitor | 5.51e-29 | 53 |
leukocyte | 4.23e-19 | 136 |
natural killer cell | 2.31e-17 | 3 |
pro-NK cell | 2.31e-17 | 3 |
hematopoietic cell | 2.77e-16 | 177 |
hematopoietic stem cell | 6.33e-16 | 168 |
mature alpha-beta T cell | 2.35e-14 | 18 |
alpha-beta T cell | 2.35e-14 | 18 |
Showing 1 to 10 of 31 entries